GBp 1173.5
(0.3%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 23.07 Billion | 21.25 Billion | 19.52 Billion | 19.27 Billion | 18.3 Billion | 16.82 Billion |
Cost of Revenue | 20.91 Billion | 15.35 Billion | 14.32 Billion | 14.13 Billion | 13.44 Billion | 5.92 Billion |
Gross Profit | 2.16 Billion | 5.9 Billion | 5.19 Billion | 5.14 Billion | 4.85 Billion | 10.89 Billion |
Operating Expenses | 12.63 Billion | 3.85 Billion | 3.32 Billion | 3.43 Billion | 3.11 Billion | 9.49 Billion |
Selling, General and Administrative Expenses | 12.63 Billion | 3.63 Billion | 3.14 Billion | 3.28 Billion | 2.97 Billion | 6.2 Billion |
Research and Development Expenses | - | 265 Million | 247 Million | 220 Million | 211 Million | 1.5 Billion |
Other Expenses | - | 40 Million | 64 Million | 63 Million | 66 Million | 46 Million |
Cost and Expenses | 20.91 Billion | 19.2 Billion | 17.65 Billion | 17.57 Billion | 16.56 Billion | 15.41 Billion |
Operating Income | 2.57 Billion | 2.05 Billion | 1.86 Billion | 1.7 Billion | 1.73 Billion | 1.52 Billion |
Interest Expense | 353 Million | 273 Million | 252 Million | 244 Million | 239 Million | 208 Million |
Income Tax Expense | 386 Million | 280 Million | 182 Million | 197 Million | 82 Million | 191 Million |
Earnings before Tax | 2.11 Billion | 1.77 Billion | 1.95 Billion | 1.49 Billion | 1.44 Billion | 1.22 Billion |
Net Income | 1.85 Billion | 1.59 Billion | 1.75 Billion | 1.29 Billion | 1.47 Billion | 1 Billion |
Earnings Per Share Basic | 0.61 | 0.51 | 0.55 | 0.41 | 0.46 | 0.31 |
Earnings Per Share Diluted | 0.60 | 0.50 | 0.55 | 0.40 | 0.46 | 0.31 |
Weighted Average Shares Outstanding | 3.03 Billion | 3.11 Billion | 3.18 Billion | 3.19 Billion | 3.18 Billion | 3.19 Billion |
Weighted Average Shares Outstanding (Diluted) | 3.07 Billion | 3.15 Billion | 3.21 Billion | 3.21 Billion | 3.2 Billion | 3.2 Billion |
Gross Margin | 0.09 | 0.28 | 0.27 | 0.27 | 0.27 | 0.65 |
EBIT Margin | 0.14 | 0.13 | 0.13 | 0.12 | 0.13 | 0.11 |
Profit Margin | 0.08 | 0.07 | 0.09 | 0.07 | 0.08 | 0.06 |
EBITDA | 3.2 Billion | 2.81 Billion | 2.9 Billion | 2.41 Billion | 2.28 Billion | 1.61 Billion |
Earnings Before Tax Margin | 0.11 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | 12.47 Billion | 12.08 Billion | 23.07 Billion | 10.99 Billion | 11.51 Billion | 21.25 Billion |
Cost of Revenue | 11.37 Billion | 10.99 Billion | 20.91 Billion | 9.92 Billion | 10.45 Billion | 15.35 Billion |
Gross Profit | 1.1 Billion | 1.09 Billion | 2.16 Billion | 1.07 Billion | 1.06 Billion | 5.9 Billion |
Operating Expenses | 263 Million | 12.8 Billion | 12.88 Billion | 236 Million | 11.81 Billion | 3.85 Billion |
Selling, General and Administrative Expenses | 6 Million | 7.95 Billion | - | 19 Million | 7.41 Billion | - |
Research and Development Expenses | - | 2.3 Billion | - | - | 2 Billion | - |
Other Expenses | - | - | 64 Million | - | - | 40 Million |
Cost and Expenses | 11.63 Billion | 10.99 Billion | 20.91 Billion | 9.92 Billion | 10.45 Billion | 19.2 Billion |
Operating Income | 1.26 Billion | 1.09 Billion | 2.16 Billion | 1.07 Billion | 1.06 Billion | 2.05 Billion |
Interest Expense | 266 Million | 115 Million | 353 Million | 116 Million | 113 Million | 273 Million |
Income Tax Expense | 175 Million | 193 Million | 386 Million | 193 Million | 183 Million | 280 Million |
Earnings before Tax | 1.16 Billion | 980 Million | 2.11 Billion | 1.13 Billion | 1.07 Billion | 1.77 Billion |
Net Income | 948 Million | 892 Million | 1.85 Billion | 965 Million | 976 Million | 1.59 Billion |
Earnings Per Share Basic | 0.31 | 0.29 | - | 0.32 | 0.31 | - |
Earnings Per Share Diluted | 0.31 | 0.29 | - | 0.31 | 0.31 | - |
Weighted Average Shares Outstanding | 3.05 Billion | 3.02 Billion | 3.03 Billion | 3.03 Billion | 3.1 Billion | 3.11 Billion |
Weighted Average Shares Outstanding (Diluted) | 3.05 Billion | 3.06 Billion | 3.07 Billion | 3.07 Billion | 3.14 Billion | 3.15 Billion |
Gross Margin | 0.09 | 0.09 | 0.09 | 0.10 | 0.09 | 0.28 |
EBIT Margin | 0.14 | 0.12 | - | 0.13 | 0.13 | - |
Profit Margin | 0.08 | 0.07 | 0.08 | 0.09 | 0.08 | 0.07 |
EBITDA | 1.76 Billion | 1.49 Billion | - | 1.45 Billion | 1.47 Billion | - |
Earnings Before Tax Margin | 0.10 | 0.09 | 0.09 | 0.10 | 0.09 | 0.10 |
CHMI-PA
SGQRF
PHARM
7942
ICCO
5254